Dorsey & Whitney Trust CO LLC Has $291,000 Stock Position in Humana Inc. (NYSE:HUM)

Dorsey & Whitney Trust CO LLC increased its position in Humana Inc. (NYSE:HUM) by 38.7% in the fourth quarter, Holdings Channel.com reports. The firm owned 1,146 shares of the insurance provider’s stock after acquiring an additional 320 shares during the period. Dorsey & Whitney Trust CO LLC’s holdings in Humana were worth $291,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. FPC Investment Advisory Inc. acquired a new stake in Humana in the fourth quarter worth about $27,000. Centricity Wealth Management LLC acquired a new stake in Humana in the fourth quarter worth about $30,000. Ashton Thomas Securities LLC acquired a new stake in Humana in the third quarter worth about $31,000. Atwood & Palmer Inc. increased its position in Humana by 64.5% in the fourth quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider’s stock worth $39,000 after purchasing an additional 60 shares during the period. Finally, Kestra Investment Management LLC acquired a new stake in Humana in the fourth quarter worth about $49,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Humana

In related news, insider Timothy S. Huval sold 3,703 shares of the firm’s stock in a transaction dated Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the sale, the insider now directly owns 8,181 shares in the company, valued at approximately $2,096,463.06. This trade represents a 31.16 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. 0.32% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

HUM has been the topic of a number of recent analyst reports. Cantor Fitzgerald restated a “neutral” rating and set a $290.00 target price on shares of Humana in a report on Wednesday, February 12th. Truist Financial upped their price objective on shares of Humana from $260.00 to $290.00 and gave the company a “hold” rating in a research report on Monday, January 6th. JPMorgan Chase & Co. lowered their price objective on shares of Humana from $257.00 to $256.00 and set a “neutral” rating for the company in a research report on Tuesday, February 18th. Barclays upped their price objective on shares of Humana from $255.00 to $270.00 and gave the company an “equal weight” rating in a research report on Thursday, February 13th. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $283.00 price objective on shares of Humana in a research report on Wednesday, February 12th. Twenty equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $285.68.

Humana Trading Down 3.2 %

Humana stock opened at $251.41 on Tuesday. The firm has a 50-day moving average of $271.74 and a 200-day moving average of $282.37. Humana Inc. has a one year low of $213.31 and a one year high of $406.46. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. The company has a market cap of $30.33 billion, a price-to-earnings ratio of 25.27, a P/E/G ratio of 2.05 and a beta of 0.57.

Humana (NYSE:HUM) last posted its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, equities analysts expect that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a dividend of $0.885 per share. The ex-dividend date is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.41%. Humana’s dividend payout ratio is 35.58%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.